Astellas Pharma US | Changing Tomorrow | Home

Previous Pause Next

C3 2020

WE CAN CHANGE CANCER CARE

Astellas Oncology opens annual C3 Prize call for entries to award best innovations in cancer care beyond medicine

revised newest covid

UPDATES AND INFORMATION

Find out how we're responding to our patients, our employees and our community

alt text

Astellas Pharma Support Solutions Helps to Address Evolving Patient Needs During COVID-19 Read More

1

2

3

News

Latest

News / Media

Jul 22, 2020

Astellas is Awarded Grant from the U.S. National Institutes of Health (NIH) to Fund Early Clinical Studies of ASP8062 to Investigate Potential Novel Therapeutic Approach to Address the Opioid Crisis

News / Media

Jul 20, 2020

Astellas Named to FTSE4Good Index Series for Ninth Consecutive Year

News / Media

Jun 05, 2020

Astellas, City of Yokohama, and Yokohama City University Developed Science-Based Exercise Programs through Industry-Government-Academia Collaboration

News / Corporate

Jul 23, 2020

Astellas Partners with LabCentral to Help Emerging Biotechs Accelerate Preclinical Scientific Research

News / Corporate

Jul 22, 2020

Astellas is Awarded Grant from the U.S. National Institutes of Health (NIH) to Fund Early Clinical Studies of ASP8062 to Investigate Potential Novel Therapeutic Approach to Address the Opioid Crisis

News / Therapeutic Area News

Jun 08, 2020

Roxadustat Demonstrates Non-Inferiority to Darbepoetin in Phase 3 DOLOMITES Study of Anemia in Non-Dialysis-Dependent Adult Patients with Chronic Kidney Disease